AI Accelerates Design of Next-Generation Medicines
Artificial intelligence is increasingly being used to assist scientists in designing new medicines, especially biologic therapies made from engineered proteins. By leveraging AI, researchers can more efficiently identify promising drug candidates, potentially reducing the time and cost associated with traditional drug development.
Why it matters: AI-driven drug design could accelerate the development of innovative treatments and improve patient outcomes.
Full story at: MIT Technology Review / AI ↗